Skip to main content
. 2017 Jan 17;31(1):75–82. doi: 10.1007/s40259-016-0209-y

Fig. 2.

Fig. 2

The proportion of patients with moderate-to-severe psoriasis switched to biologics over time (switch rate), for Sweden and for the regions with the highest and lowest switch rates